{"id":54861,"date":"2023-03-15T14:03:12","date_gmt":"2023-03-15T13:03:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/"},"modified":"2023-03-15T14:03:12","modified_gmt":"2023-03-15T13:03:12","slug":"edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/","title":{"rendered":"Edgeworth Economics\u2019 Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog"},"content":{"rendered":"
\n

WASHINGTON–(BUSINESS WIRE)–Edgeworth Economics today debuts The Antitrust Prescription,<\/i> the firm\u2019s new blog that covers antitrust and other economic issues affecting companies in the pharmaceutical industry. In the blog, Edgeworth\u2019s experts provide legal practitioners and pharmaceutical company leaders with the latest economic insights and information impacting business in this constantly-evolving industry.\n<\/p>\n

<\/a><\/p>\n

\nThe blog is an industry resource provided by Edgeworth\u2019s Pharmaceutical Economics practice, which is dedicated to assisting companies and legal counsel with the most pressing economic issues in the space. With deep expertise in the pharmaceutical, healthcare and broader life sciences industries, Edgeworth\u2019s coast-to-coast team of expert economists provides thoughtful and accessible insights on a regular basis to companies interested in the economic dimensions of common legal questions in the areas of antitrust and competition, false claims, product misrepresentation, consumer protection, intellectual property, valuation, and contract disputes. The Antitrust Prescription<\/i> will spotlight economic topics surrounding legal issues including class certification, liability, and damages, and will provide expert commentary on common claims such as pay for delay, product hopping, exclusive contracting, monopolization, bid rigging, price fixing, and foreclosure.\n<\/p>\n

\nVisit The Antitrust Prescription<\/i> <\/b>here<\/b><\/a> and follow us on social media using #EE_TheAntitrustPrescription.<\/b>\n<\/p>\n

\nLearn more about Edgeworth\u2019s Pharmaceutical Economics practice here.<\/b><\/a>\n<\/p>\n

\nEdgeworth Economics has deep experience analyzing economic and econometric issues in the pharmaceutical industry in the areas of antitrust, intellectual property, commercial damages, and consumer protection. Since our founding in 2009, Edgeworth\u2019s economists have served as both testifying and consulting economists on a wide array of industry-specific matters before courts and regulatory authorities. Our pharmaceutical economics experts have assisted clients across the industry, including brand and generic pharmaceutical companies, biotechnology companies, product manufacturers, healthcare providers, and insurers.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nDr. George Korenko, Partner \u2013 gkorenko@edgewortheconomics.com<\/a>\n<\/p>\n

\nDr. Tram Nguyen, Managing Principal \u2013 tnguyen@edgewortheconomics.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WASHINGTON–(BUSINESS WIRE)–Edgeworth Economics today debuts The Antitrust Prescription, the firm\u2019s new blog that covers antitrust and other economic issues affecting companies in the pharmaceutical industry. In the blog, Edgeworth\u2019s experts provide legal practitioners and pharmaceutical company leaders with the latest economic insights and information impacting business in this constantly-evolving industry. The blog is an industry … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54861","6":"format-standard","7":"category-industry"},"yoast_head":"\nEdgeworth Economics\u2019 Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Edgeworth Economics\u2019 Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WASHINGTON–(BUSINESS WIRE)–Edgeworth Economics today debuts The Antitrust Prescription, the firm\u2019s new blog that covers antitrust and other economic issues affecting companies in the pharmaceutical industry. In the blog, Edgeworth\u2019s experts provide legal practitioners and pharmaceutical company leaders with the latest economic insights and information impacting business in this constantly-evolving industry. The blog is an industry ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-15T13:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230315005209\/en\/775414\/21\/Edgeworth_Economics_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Edgeworth Economics\u2019 Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog\",\"datePublished\":\"2023-03-15T13:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\\\/\"},\"wordCount\":309,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230315005209\\\/en\\\/775414\\\/21\\\/Edgeworth_Economics_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\\\/\",\"name\":\"Edgeworth Economics\u2019 Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230315005209\\\/en\\\/775414\\\/21\\\/Edgeworth_Economics_logo.jpg\",\"datePublished\":\"2023-03-15T13:03:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230315005209\\\/en\\\/775414\\\/21\\\/Edgeworth_Economics_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230315005209\\\/en\\\/775414\\\/21\\\/Edgeworth_Economics_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Edgeworth Economics\u2019 Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Edgeworth Economics\u2019 Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/","og_locale":"en_US","og_type":"article","og_title":"Edgeworth Economics\u2019 Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog - Pharma Trend","og_description":"WASHINGTON–(BUSINESS WIRE)–Edgeworth Economics today debuts The Antitrust Prescription, the firm\u2019s new blog that covers antitrust and other economic issues affecting companies in the pharmaceutical industry. In the blog, Edgeworth\u2019s experts provide legal practitioners and pharmaceutical company leaders with the latest economic insights and information impacting business in this constantly-evolving industry. The blog is an industry ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-15T13:03:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230315005209\/en\/775414\/21\/Edgeworth_Economics_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Edgeworth Economics\u2019 Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog","datePublished":"2023-03-15T13:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/"},"wordCount":309,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230315005209\/en\/775414\/21\/Edgeworth_Economics_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/","url":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/","name":"Edgeworth Economics\u2019 Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230315005209\/en\/775414\/21\/Edgeworth_Economics_logo.jpg","datePublished":"2023-03-15T13:03:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230315005209\/en\/775414\/21\/Edgeworth_Economics_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230315005209\/en\/775414\/21\/Edgeworth_Economics_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/edgeworth-economics-pharmaceutical-economics-practice-launches-the-antitrust-prescription-blog\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Edgeworth Economics\u2019 Pharmaceutical Economics Practice Launches The Antitrust Prescription Blog"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54861","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54861"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54861\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}